Effect of ketogenic diet on alzheimer's disease to improve cognitive function: A literature review
Abstract
Background: Alzheimer's is the most common cause of neurodegenerative dementia which is characterized by reduced cognitive function. Alzheimer's disease is a serious global problem because so far no effective treatment has been found to prevent it. Improving diet can be used as therapy to prevent cognitive decline. The ketogenic diet is one of the recommended therapies because it is neuroprotective.
Purpose: To review several studies related to the effect of giving a ketogenic diet in improving cognitive function in people with Alzheimer's.
Method: This study used the literature review method using the PRISMA protocol. Literature searches were conducted online, sourced from Scopus, Science Direct, PubMed, ProQuest, and SpringerLink databases by entering a number of relevant keywords. The key words are "ketogenic diet" AND "alzheimer's disease" AND "cognitive function" OR "improves cognition". The conditions for the inclusion of the reviewed articles are publications for the last five years (2018 - 2023), in English, open access, and include research articles or original articles. The feasibility of this study was assessed by applying the PICO framework, including the samples used were humans or experimental animals suffering from Alzheimer's, the sample received a ketogenic diet intervention.
Results: Showed an effect of the ketogenic diet on cognitive function in Alzheimer's patients. There were four articles reviewed where all articles examined the effect of giving a ketogenic diet on cognitive function in Alzheimer's sufferers. The ketogenic diet is a high-fat, low-carb diet that promotes the process of ketogenesis. The resulting ketone bodies, such as acetoacetate and β-hydroxybutyrate can meet the energy needs of brain cells and improve memory performance. The chronic effect of giving a ketogenic diet has been shown to increase cognitive test scores. However, acute administration of the ketogenic diet is still not known with certainty.
Conclusions: The chronic intervention of the ketogenic diet has a positive effect on improving the cognitive function of Alzheimer's sufferers. The ketogenic diet has been shown to be safe, feasible, and recommended as a treatment method for Alzheimer's patients.
Keywords
References
Barnard, N. D., Bush, A. I., Ceccarelli, A., Cooper, J., de Jager, C. A., Erickson, K. I., & Squitti, R. (2014). Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiology of aging, 35, S74-S78.
Bough, K. J., Wetherington, J., Hassel, B., Pare, J. F., Gawryluk, J. W., Greene, J. G., & Dingledine, R. J. (2006). Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 60(2), 223-235.
Caselli, R. J., Beach, T. G., Knopman, D. S., & Graff-Radford, N. R. (2017, June). Alzheimer disease: scientific breakthroughs and translational challenges. In Mayo Clinic Proceedings (Vol. 92, No. 6, pp. 978-994). Elsevier.
Castellano, C. A., Nugent, S., Paquet, N., Tremblay, S., Bocti, C., Lacombe, G., & Cunnane, S. C. (2015). Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia. Journal of Alzheimer's Disease, 43(4), 1343-1353.
Chowdhury, G. M., Jiang, L., Rothman, D. L., & Behar, K. L. (2014). The contribution of ketone bodies to basal and activity-dependent neuronal oxidation in vivo. Journal of Cerebral Blood Flow & Metabolism, 34(7), 1233-1242..
Cunnane, S., Nugent, S., Roy, M., Courchesne-Loyer, A., Croteau, E., Tremblay, S., & Rapoport, S. I. (2011). Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition, 27(1), 3-20.
Das, T. K., Chakrabarti, S. K., Zulkipli, I. N., & Abdul Hamid, M. R. (2019). Curcumin ameliorates the impaired insulin signaling involved in the pathogenesis of Alzheimer’s disease in rats. Journal of Alzheimer's Disease Reports, 3(1), 59-70.
De la Monte, S. M. (2017). Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for Alzheimer’s disease. Drugs, 77, 47-65.
Hasselbalch, S. G., Knudsen, G. M., Jakobsen, J., Hageman, L. P., Holm, S., & Paulson, O. B. (1994). Brain metabolism during short-term starvation in humans. Journal of cerebral blood flow & metabolism, 14(1), 125-131.
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011). Alzheimer’s disease: the challenge of the second century. Science translational medicine, 3(77), 77sr1-77sr1.
Khoury, R., & Ghossoub, E. (2019). Diagnostic biomarkers of Alzheimer’s disease: a state-of-the-art review. Biomarkers in Neuropsychiatry, 1, 100005.
Koppel, S. J., & Swerdlow, R. H. (2018). Neuroketotherapeutics: a modern review of a century-old therapy. Neurochemistry international, 117, 114-125..
Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2012). Dietary ketosis enhances memory in mild cognitive impairment. Neurobiology of aging, 33(2), 425-e19.
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H., & Häring, H. U. (2016). Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiological reviews.
Lange, K. W., Lange, K. M., Makulska-Gertruda, E., Nakamura, Y., Reissmann, A., Kanaya, S., & Hauser, J. (2017). Ketogenic diets and Alzheimer’s disease. Food Science and Human Wellness, 6(1), 1-9.
McDonald, T. J., & Cervenka, M. C. (2018). Ketogenic diets for adult neurological disorders. Neurotherapeutics, 15, 1018-1031.
McDonald, T. J., & Cervenka, M. C. (2018). The expanding role of ketogenic diets in adult neurological disorders. Brain sciences, 8(8), 148.
McGrattan, A. M., McGuinness, B., McKinley, M. C., Kee, F., Passmore, P., Woodside, J. V., & McEvoy, C. T. (2019). Diet and inflammation in cognitive ageing and Alzheimer’s disease. Current nutrition reports, 8, 53-65.
Mirzaei, G., & Adeli, H. (2022). Machine learning techniques for diagnosis of alzheimer disease, mild cognitive disorder, and other types of dementia. Biomedical Signal Processing and Control, 72, 103293.
Omar, S. H. (2019). Mediterranean and MIND diets containing olive biophenols reduces the prevalence of Alzheimer’s disease. International journal of molecular sciences, 20(11), 2797.
Ota, M., Matsuo, J., Ishida, I., Takano, H., Yokoi, Y., Hori, H., & Kunugi, H. (2019). Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease. Neuroscience letters, 690, 232-236.
Paoli, A., Bianco, A., Damiani, E., & Bosco, G. (2014). Ketogenic diet in neuromuscular and neurodegenerative diseases. BioMed research international, 2014.
Phillips, M. C., Deprez, L. M., Mortimer, G., Murtagh, D. K., McCoy, S., Mylchreest, R., & Schepel, J. A. (2021). Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease. Alzheimer's research & therapy, 13(1), 1-12.
Rajan, K. B., Wilson, R. S., Weuve, J., Barnes, L. L., & Evans, D. A. (2015). Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia. Neurology, 85(10), 898-904.
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019). Ketogenic diet in Alzheimer’s disease. International journal of molecular sciences, 20(16), 3892.
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harbor perspectives in medicine, 1(1), a006189..
Smith, P. J., Blumenthal, J. A., Babyak, M. A., Craighead, L., Welsh-Bohmer, K. A., Browndyke, J. N., & Sherwood, A. (2010). Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension, 55(6), 1331-1338..
Swerdlow, R. H. (2011). Brain aging, Alzheimer's disease, and mitochondria. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1812(12), 1630-1639.
Taylor, M. K., Sullivan, D. K., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2018). Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 4, 28-36.
Taylor, M. K., Swerdlow, R. H., Burns, J. M., & Sullivan, D. K. (2019). An experimental ketogenic diet for Alzheimer disease was nutritionally dense and rich in vegetables and avocado. Current developments in nutrition, 3(4), nzz003.
Torosyan, N., Sethanandha, C., Grill, J. D., Dilley, M. L., Lee, J., Cummings, J. L., & Silverman, D. H. (2018). Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: results of a randomized, double-blinded, pilot study. Experimental gerontology, 111, 118-121.
Xu, Y., Jiang, C., Wu, J., Liu, P., Deng, X., Zhang, Y., Peng, B., & Zhu, Y. (2022). Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer’s disease. CNS Neuroscience & Therapeutics, 28(4), 580-592.
DOI: https://doi.org/10.33024/minh.v6i4.11557
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Malahayati International Journal of Nursing and Health Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.